Showing results (371-380 of 527) with videos related to
Sort By:
Pageof 53
Inflammatory Bowel Diseases|December 17, 2009
Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: results of the FACTS surveyAlain M Schoepfer, Stephan R Vavricka, Janek Binek, et al.Plos One|August 14, 2014
Hemoglobin and hematocrit levels in the prediction of complicated Crohn's disease behavior--a cohort studyFlorian Rieder, Gisela Paul, Elisabeth Schnoy, et al.Journal of Crohn'S & Colitis|October 14, 2017
Genital Granulomatosis in Male and Female Patients With Crohn's Disease: Clinical Presentation and Treatment OutcomesFrank Dederichs, Igor Iesalnieks, Malgrozata Sladek, et al.Scientific Reports|January 31, 2020
Activation of pH-Sensing Receptor OGR1 (GPR68) Induces ER Stress Via the IRE1α/JNK Pathway in an Intestinal Epithelial Cell ModelChiaki Maeyashiki, Hassan Melhem, Larissa Hering, et al.Gastrointestinal Endoscopy|February 18, 2021
Evaluating key characteristics of ideal colorectal cancer screening modalities: the microsimulation approachAnsgar Deibel, Lu Deng, Chih-Yuan Cheng, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 30, 2021
Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel diseasePaula Sousa, Paula Ministro, Alessandro Armuzzi, et al.The Journal of Biological Chemistry|June 16, 2011
BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cellsMartin Hausmann, Katharina Leucht, Christian Ploner, et al.Plos One|October 13, 2017
Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseasesStefania Fagagnini, Henriette Heinrich, Jean-Benoît Rossel, et al.The American Journal of Gastroenterology|June 5, 2013
CYP3A4-catalyzed simvastatin metabolism as a non-invasive marker of small intestinal health in celiac diseaseBelén Morón, Anil K Verma, Prasenjit Das, et al.BMC Genomics|September 11, 2016
Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screeningMichael K Kiessling, Sven Schuierer, Silke Stertz, et al.Pageof 53